At the Infectious Diseases Society of America Meeting, in New Orleans, Louisiana, Octavio Ramilo, MD, Nationwide Children’s Hospital, Columbus, Ohio, gave a lecture on advancements being made when it comes to host response and pathogenesis of respiratory syncytial virus.
The nation’s top public health officials believes the disease is destined to spread across the United States in the coming months.
Thirty years after the 1980s AIDS crisis, researchers have proven that Gaétan Dugas, known as Patient Zero, was, in fact, not the first AIDS case.
Vaccines are generally quite safe, but a recent study of BCG, DTP, and MCV raises concerns that warrant further exploration.
Despite public outcry, experts agree that vector-control methods are still the most effective ways to fight the spread of the Zika virus.
Researchers from Sweden’s Linköping University discover the pathway that leads to deadly infections in people co-infected with HIV and TB.
New cases of Zika are impacting Florida’s “Little Haiti” neighborhood.
The CDC Foundation and the Florida Department of Health have announced that the the Pfizer Foundation has donated millions to improve Zika response efforts.
The Georgia HCV Elimination Program, the first of its kind, is being heralded as a model for other countries that face a high rate of HCV infection.
With social media serving as a news source to so many, researchers from the Medical College of Wisconsin and the Tulane University School of Medicine studied how Facebook users are talking about the Zika virus.
During the 2016 HIV Research and Prevention (HIVR4P) meeting in Chicago, researchers conducting trials to assess the safety and efficacy of the dapivirine vaginal ring announced several key findings and insights of the ASPIRE study, known as MTN-020.
The Centers for Disease Control and Prevention reported a rise in STDs and a dent in preventive services in their 2015 Sexually Transmitted Disease Surveillance report.
The United Nations Children’s Fund (UNICEF) has partnered with six vaccine makers and the Global Alliance for Vaccines and Immunization (GAVI) to offer 450 million doses of an inexpensive pentavalent vaccine for children.
As the flu hits New Mexico, hundreds are reporting symptoms, while infection has only been lab-confirmed in two cases.
Health leaders call for manufacturers to consider the customer when developing diagnostic tests and discuss the need to develop direct-from-specimen tests to characterize pathogens.
The US Food and Drug Administration has approved Merck’s Zinplava, a monoclonal antibody that will reduce recurrence of Clostridium difficile in high risk patients.
Experts in clinical diagnostics and tracking food-borne outbreaks discuss using culture-independent diagnostic tests (CIDTs) as well as how the use of CIDTs is currently working in Colorado.
The first influenza cases of the 2016-2017 season were reported by the Minnesota Department of Health, a reminder for state residents to receive influenza vaccination.
New studies on the Zika virus have revealed how long the virus may stay in the vaginal tract, as UK researchers have mapped the first complete Zika virus genome derived from semen.
An employee in the prepared foods section of a Whole Foods Market in Detroit, Michigan, has been diagnosed with hepatitis A.
A new study shows that using antimicrobial copper can kill surface bacteria and minimize pathogens in hospital rooms.
Changes in strain prevalence indicate that the existing 9-valent HPV vaccines may offer some protection against an additional high-risk strain that is not included in the vaccine (strain 31), potentially due to antigenic similarities with other strains.
A new CDC study suggests that a closer look at the epidemiology of cat scratch disease may help prevent infections.
The first days of life are crucial for any newborn, and a new study has found that a protein in breast milk plays an important role in protecting infants from catching hospital-acquired infections.
A mutated version of Yersinia pestis may hold the key to vaccines for the plague.
The CDC warns that open-heart surgery patients are at increased risk of infection due to contaminated heater-cooler devices.
Research groups from around the world have identified potential therapeutic targets for treating active Zika virus.
While health officials continue to search for more novel tools to fight tuberculosis, a team of researchers has found that a class of antibiotics first introduced in the 1960s may offer an important weapon against the outbreaks of today.
Researchers at Sanofi Pasteur, have developed a “transmission model” for Dengue and assessed the population impact of vaccination in the 10 countries participating in the Phase III efficacy studies for CYD-TDV/Dengvaxia.
Researchers from the United Kingdom and Brazil have isolated the full-length genome sequence of the Zika virus.
